Empagliflozin and linagliptin and Inotuzumab ozogamicin
Determining the interaction of Empagliflozin and linagliptin and Inotuzumab ozogamicin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
Generic Name: inotuzumab ozogamicin
Brand name: Besponsa
Synonyms: Inotuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Empagliflozin and linagliptin-Inotuzumab ozogamicin Intravenous
- Empagliflozin and linagliptin-Inova
- Empagliflozin and linagliptin-Inova 4/1 topical
- Empagliflozin and linagliptin-Inova 8/2 topical
- Empagliflozin and linagliptin-Inova ACT
- Empagliflozin and linagliptin-Inrebic
- Inotuzumab ozogamicin-Empagliflozin and metformin
- Inotuzumab ozogamicin-Empagliflozin and Metformin Extended-Release Tablets
- Inotuzumab ozogamicin-Empagliflozin and Metformin Tablets
- Inotuzumab ozogamicin-Empliciti
- Inotuzumab ozogamicin-Emsam
- Inotuzumab ozogamicin-Emsam Transdermal